HIGHLIGHTS
- who: Fuwei Liu from the Department of Cardiology, Guizhou Provincial People`s Hospital, Guiyang, China, Second Clinical Medical College, Nanchang University, Nanchang, China, Department of Cardiology, The Affiliated Ganzhou Hospital of Nanchang University have published the paper: An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve, in the Journal: (JOURNAL)
- what: The authors included the randomized controlled trials (RCTs), posthoc analyses of RCTs and observational cohort studies focusing on the effectiveness and/or safety of DOACs (dabigatran, rivaroxaban, apixaban, or edoxaban) compared with VKAs in AF patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.